Status:
COMPLETED
The Asian Transcatheter Aortic Valve Replacement Registry
Lead Sponsor:
Seung-Jung Park
Collaborating Sponsors:
CardioVascular Research Foundation, Korea
Conditions:
Aortic Valve Stenosis
Aortic Diseases
Eligibility:
All Genders
Brief Summary
The purpose of this study is to evaluate the clinical outcomes of transcatheter aortic valve replacement (TAVR) in the Asian Pacific population
Detailed Description
This registry changes to TP-TAVR registry(NCT03826264). Some subjects moved to TP-TAVR registry and continue to 10-year follow-up.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with symptomatic severe aortic stenosis who are not candidates for surgical aortic valve replacement because of coexisting illnesses
- The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site
Exclusion
Key Trial Info
Start Date :
December 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 24 2019
Estimated Enrollment :
1505 Patients enrolled
Trial Details
Trial ID
NCT02308150
Start Date
December 1 2014
End Date
September 24 2019
Last Update
September 25 2019
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Elizabeth Hospital
Hong Kong, China
2
Shonan Kamakura General Hospital
Kamakura, Japan
3
Kokura Memorial Hospital
Kitakyushu, Japan
4
Keio University
Minato, Japan